Kewei Ma

3.8k total citations · 1 hit paper
131 papers, 2.5k citations indexed

About

Kewei Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kewei Ma has authored 131 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 38 papers in Molecular Biology. Recurrent topics in Kewei Ma's work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Kewei Ma is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Kewei Ma collaborates with scholars based in China, United States and Canada. Kewei Ma's co-authors include Yinghui Xu, Shi Qiu, Ye Guo, Chao Sun, Xu Wang, Zhenguo Wu, Vincent Duronio, Aaron J. Marshall, Guang Zhu and Jonathan Chan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kewei Ma

110 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review of asymptomatic infections with COVID-19

2020 608 citations Yinghui Xu, Chao Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kewei Ma China	23	1.1k	612	446	444	303	131	2.5k
Yu Shi China	31	1.3k 1.2×	463 0.8×	253 0.6×	226 0.5×	285 0.9×	129	2.8k
Tony R. Reid United States	20	696 0.7×	1.1k 1.8×	317 0.7×	184 0.4×	296 1.0×	66	2.1k
Yi Fang China	28	1.5k 1.5×	691 1.1×	303 0.7×	147 0.3×	401 1.3×	127	3.0k
Antonio Giovanni Solimando Italy	38	1.3k 1.2×	1.1k 1.8×	473 1.1×	135 0.3×	500 1.7×	129	3.1k
Chian‐Shiu Chien Taiwan	25	1.5k 1.4×	669 1.1×	142 0.3×	527 1.2×	162 0.5×	57	2.8k
Yu Jiang China	27	667 0.6×	1.0k 1.7×	277 0.6×	100 0.2×	357 1.2×	119	2.5k
Min Dai China	30	920 0.9×	299 0.5×	199 0.4×	202 0.5×	628 2.1×	161	2.9k

Countries citing papers authored by Kewei Ma

Since Specialization

Citations

This map shows the geographic impact of Kewei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Ma more than expected).

Fields of papers citing papers by Kewei Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Ma. The network helps show where Kewei Ma may publish in the future.

Co-authorship network of co-authors of Kewei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Ma. A scholar is included among the top collaborators of Kewei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Ma. Kewei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuchen, Xiaobo Ma, Kewei Ma, et al.. (2025). Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study. Frontiers in Immunology. 15. 1479263–1479263.

Ma, Kewei, et al.. (2024). Efficient solar-driven ammonia decomposition using economical K-Co3Mo3N catalyst at low temperatures. Chemical Engineering Journal. 496. 153658–153658. 8 indexed citations

Wu, Zhonghua, et al.. (2024). Fixed-time neural network composite learning control for uncertain nonlinear systems. Engineering Applications of Artificial Intelligence. 141. 109722–109722. 1 indexed citations

Sun, Puyang, Kewei Ma, & Li Su. (2024). Import licenses, intermediaries, and price pass-through: Evidence from the Chinese steel market. Journal of International Money and Finance. 149. 103209–103209.

Li, Xiaoning, et al.. (2024). Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review. Frontiers in Immunology. 15. 1486214–1486214. 1 indexed citations

Liu, Yiqian, Liyun Miao, Xiao Chen, et al.. (2024). Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials. Medicine. 103(27). e38459–e38459. 1 indexed citations

Ma, Kewei, Xiangyu Wang, Songhui Zhao, et al.. (2023). P2.07-01 Development of Postoperative Bronchopleural Fistula after Neoadjuvant Immunochemotherapy in Non-small Cell Lung Cancer: Case Reports. Journal of Thoracic Oncology. 18(11). S322–S323.

Xia, Qi, et al.. (2023). Efficient solar hydrocarbon fuel production by integrating Fischer-Tropsch synthesis with high-temperature solid oxide co-electrolysis and electrolysis. Energy Conversion and Management. 294. 117598–117598. 10 indexed citations

Ma, Kewei, Xiaobo Ma, Xu Wang, et al.. (2023). Imaging Findings Can’t Mean Everything in the Era of Immunotherapy: A Case Report and Literature Review. Immunotherapy. 16(2). 99–106. 2 indexed citations

10.

Ye, Jianyu, Peixin Huang, Kewei Ma, et al.. (2023). Genome-Wide Extrachromosomal Circular DNA Profiling of Paired Hepatocellular Carcinoma and Adjacent Liver Tissues. Cancers. 15(22). 5309–5309. 5 indexed citations

11.

Xu, Yinghui, Xiaobo Ma, Xu Wang, et al.. (2022). Efficacy of Immunotherapy Combined with Antiangiogenic Therapy in Treatment-Failure Patients with Advanced Carcinoma Ex Pleomorphic Adenoma of the Submandibular Gland: A Case Report. Current Oncology. 29(9). 6334–6341.

12.

Chen, Xi & Kewei Ma. (2021). Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?. Current Oncology. 28(5). 4129–4138. 12 indexed citations

13.

Sun, Mengyao, Xu Wang, Yinghui Xu, et al.. (2021). Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between different lesions. Thoracic Cancer. 13(3). 514–516. 6 indexed citations

14.

Xu, Yinghui, Zhiguang Yang, Yunpeng Liu, et al.. (2021). Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis. Thoracic Cancer. 12(5). 693–698. 2 indexed citations

15.

Ma, Kewei, et al.. (2020). Fasudil protects against isoproterenol-induced myocardial infarction in mice via inhibiting Rho/ROCK signaling pathway. SHILAP Revista de lepidopterología. 4 indexed citations

16.

Sun, Mengyao, Ye Guo, Xu Wang, et al.. (2020). Long-term response to second-line afatinib treatment for advanced squamous cell carcinoma non-small cell lung cancer: a rare case report. Journal of International Medical Research. 48(10). 1220764252–1220764252. 1 indexed citations

17.

Xu, Yinghui, Xu Wang, Yunpeng Liu, et al.. (2020). Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report. Thoracic Cancer. 11(8). 2361–2364. 3 indexed citations

18.

Ma, Kewei, et al.. (2019). Identification of key genes, pathways and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis. SHILAP Revista de lepidopterología. 2 indexed citations

19.

Huang, Xiaohua, Li Y, Jianbin Zhang, et al.. (2013). Ganglioside GM3 inhibits hepatoma cell motility via down‐regulating activity of EGFR and PI3K/AKT signaling pathway. Journal of Cellular Biochemistry. 114(7). 1616–1624. 33 indexed citations

20.

Ong, Christopher J., Andrew Ming‐Lum, Matt Nodwell, et al.. (2007). Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood. 110(6). 1942–1949. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Shi Breakdown of academic impact, for papers by Tony R. Reid Breakdown of academic impact, for papers by Yi Fang Breakdown of academic impact, for papers by Antonio Giovanni Solimando Breakdown of academic impact, for papers by Chian‐Shiu Chien Breakdown of academic impact, for papers by Yu Jiang Breakdown of academic impact, for papers by Min Dai